标题
Denosumab in osteoporosis
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 13, Issue 2, Pages 247-253
出版商
Informa Healthcare
发表日期
2013-12-02
DOI
10.1517/14740338.2014.860133
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of the Risk Factors Associated with Hypocalcemia Induced by Denosumab
- (2013) Naoto Okada et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A Case of an Unusual Subtrochanteric Fracture in a Patient Receiving Denosumab
- (2013) Rodis Paparodis et al. Endocrine Practice
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Severe symptomatic hypocalcaemia following a single dose of denosumab
- (2013) Jennifer M McLachlan et al. MEDICAL JOURNAL OF AUSTRALIA
- Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
- (2013) Areti Augoulea et al. International Journal of Endocrinology
- Cost–effectiveness of denosumab in the treatment of postmenopausal osteoporotic women
- (2013) Mickaël Hiligsmann et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The role of osteoprotegerin in cardiovascular disease
- (2012) Martina Montagnana et al. ANNALS OF MEDICINE
- Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP
- (2012) R. Mogelvang et al. HEART
- Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease
- (2012) Dimitris Tousoulis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing
- (2012) Silvano Adami et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- A single-dose study of denosumab in patients with various degrees of renal impairment
- (2012) Geoffrey A Block et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
- (2012) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
- (2012) Eric Orwoll et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis
- (2011) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on fracture and bone mineral density by level of kidney function
- (2011) Sophie A Jamal et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk
- (2011) S. Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
- (2011) N. B. Watts et al. OSTEOPOROSIS INTERNATIONAL
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
- (2011) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
- (2010) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate
- (2010) D. L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
- (2010) B. Jönsson et al. OSTEOPOROSIS INTERNATIONAL
- Inhibition of Receptor Activator of NF-κB Ligand by Denosumab Attenuates Vascular Calcium Deposition in Mice
- (2009) Susann Helas et al. AMERICAN JOURNAL OF PATHOLOGY
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
- (2008) Sean Morony et al. CIRCULATION
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now